logo

Cellular Biomedicine Group Inc. (CBMG)



Trade CBMG now with
  Date
  Headline
3/14/2016 7:23:09 AM Cellular Biomedicine 2015 Revenue $2.5 Mln Vs. $0.6 Mln Last Year
2/4/2016 9:10:27 AM Cellular Biomedicine Announces $43.13 Mln Strategic Investment From Dangdai International
1/28/2016 6:09:34 AM Cellular Biomedicine Names Tony (Bizuo) Liu As CEO Effective Feb 7
1/11/2016 9:12:51 AM Cellular Biomedicine : Cao Will Not Seek Renewal Of Employment Contract As CEO Upon Completion Of Current Term On Feb 6
11/13/2015 9:26:02 AM Cellular Biomedicine Q3 Loss/shr $0.44 Vs. Loss/shr $0.31 Prior Year
11/3/2015 9:28:06 AM CBMG Responds On Phase IIa Results From CAR-T CD20 Immuno-Oncology Clinical Development Program For Advanced B-cell NHL
10/23/2015 8:17:15 AM Cellular Biomedicine To Present Phase IIa Results From CAR-T CD20 Immuno-Oncology Clinical Development Program
9/28/2015 9:13:10 AM Cellular Biomedicine Reports Results From Expanded Phase I/II Clinical Trial
9/28/2015 7:38:17 AM Cellular Responds To Inquiries From Investors And Scientific Community About Immuno-Oncology Cell Therapy Platform
8/14/2015 7:11:33 AM Cellular Biomedicine Q2 Loss Per Share $0.44 Vs Loss $0.85 Last Year
6/30/2015 9:21:01 AM Cellular Biomedicine Group Responds To Class Action Lawsuit
6/9/2015 8:40:19 AM Cellular Biomedicine Group To Acquire CD40LGVAX Vaccine And Related Technologies And Know-How
5/22/2015 9:25:56 AM Cellular Biomedicine Reports Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program
5/18/2015 6:30:23 AM Cellular Biomedicine Group Q1 Loss/shr $0.39 Vs. Loss/shr $0.06 Prior Year
4/22/2015 9:40:07 AM Cellular Biomedicine Reports New Facility In Beijing
4/20/2015 9:21:08 AM Cellular Biomedicine Engages Huntsworth To Build Global KOL Advocacy For Knee Osteoarthritis Stem Cell ReJoin Trials
4/8/2015 9:54:16 AM Cellular Biomedicine Responds To False Statements And Allegations Made By Short Seller
4/6/2015 9:06:58 AM Cellular Biomedicine's Shanghai Facility Passes Fourth Consecutive CFDA Inspection
  
 
>